Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.

Zhang X, Qi Z, Du Z, Bi Y, Zhang Q, Tan Y, Yang H, Xin Y, Yang R, Wang X.

Vaccine. 2013 May 24;31(22):2539-42. doi: 10.1016/j.vaccine.2013.03.054. Epub 2013 Apr 12.

PMID:
23588087
2.

Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.

Zhang Q, Wang Q, Tian G, Qi Z, Zhang X, Wu X, Qiu Y, Bi Y, Yang X, Xin Y, He J, Zhou J, Zeng L, Yang R, Wang X.

Hum Vaccin Immunother. 2014;10(2):368-77. doi: 10.4161/hv.27060. Epub 2013 Nov 13.

3.

Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.

Derbise A, Hanada Y, Khalifé M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004162. doi: 10.1371/journal.pntd.0004162. eCollection 2015.

4.

An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.

Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2012;6(2):e1528. doi: 10.1371/journal.pntd.0001528. Epub 2012 Feb 14.

5.

Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Sun W, Roland KL, Kuang X, Branger CG, Curtiss R 3rd.

Infect Immun. 2010 Mar;78(3):1304-13. doi: 10.1128/IAI.01122-09. Epub 2010 Jan 19.

6.

Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.

Tiner BL, Sha J, Ponnusamy D, Baze WB, Fitts EC, Popov VL, van Lier CJ, Erova TE, Chopra AK.

Clin Vaccine Immunol. 2015 Dec;22(12):1255-68. doi: 10.1128/CVI.00499-15. Epub 2015 Oct 7.

7.

Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.

Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R 3rd.

Vaccine. 2010 Dec 16;29(2):274-82. doi: 10.1016/j.vaccine.2010.10.033. Epub 2010 Oct 24.

8.

A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.

Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP.

Vaccine. 2007 Nov 1;25(44):7620-8. Epub 2007 Sep 14.

PMID:
17913308
9.

A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.

Bozue J, Cote CK, Webster W, Bassett A, Tobery S, Little S, Swietnicki W.

FEMS Microbiol Lett. 2012 Jul;332(2):113-21. doi: 10.1111/j.1574-6968.2012.02583.x. Epub 2012 May 21.

10.

A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.

Oyston PC, Mellado-Sanchez G, Pasetti MF, Nataro JP, Titball RW, Atkins HS.

Microb Pathog. 2010 May;48(5):191-5. doi: 10.1016/j.micpath.2010.01.005. Epub 2010 Jan 22.

11.

Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK.

Clin Vaccine Immunol. 2013 Feb;20(2):227-38. doi: 10.1128/CVI.00597-12. Epub 2012 Dec 12.

12.

The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.

Okan NA, Mena P, Benach JL, Bliska JB, Karzai AW.

Infect Immun. 2010 Mar;78(3):1284-93. doi: 10.1128/IAI.00976-09. Epub 2010 Jan 11.

13.

Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Quenee LE, Cornelius CA, Ciletti NA, Elli D, Schneewind O.

Infect Immun. 2008 May;76(5):2025-36. doi: 10.1128/IAI.00105-08. Epub 2008 Mar 17.

14.

D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.

Szaba FM, Kummer LW, Wilhelm LB, Lin JS, Parent MA, Montminy-Paquette SW, Lien E, Johnson LL, Smiley ST.

Infect Immun. 2009 Oct;77(10):4295-304. doi: 10.1128/IAI.00273-09. Epub 2009 Jul 20.

15.

Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.

Bubeck SS, Dube PH.

Clin Vaccine Immunol. 2007 Sep;14(9):1235-8. Epub 2007 Jul 25.

16.

Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.

van Lier CJ, Sha J, Kirtley ML, Cao A, Tiner BL, Erova TE, Cong Y, Kozlova EV, Popov VL, Baze WB, Chopra AK.

Infect Immun. 2014 Jun;82(6):2485-503. doi: 10.1128/IAI.01595-13. Epub 2014 Mar 31.

17.

TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.

Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST.

Vaccine. 2010 Dec 16;29(2):357-62. doi: 10.1016/j.vaccine.2010.08.099. Epub 2010 Sep 15.

18.

A dam mutant of Yersinia pestis is attenuated and induces protection against plague.

Robinson VL, Oyston PC, Titball RW.

FEMS Microbiol Lett. 2005 Nov 15;252(2):251-6. Epub 2005 Sep 15.

19.

Live-attenuated Yersinia pestis vaccines.

Wang X, Zhang X, Zhou D, Yang R.

Expert Rev Vaccines. 2013 Jun;12(6):677-86. doi: 10.1586/erv.13.42. Review.

PMID:
23750796
20.

Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.

Ali R, Naqvi RA, Kumar S, Bhat AA, Rao DN.

Scand J Immunol. 2013 May;77(5):361-71. doi: 10.1111/sji.12042.

Supplemental Content

Support Center